Bulletin
Investor Alert

Context Therapeutics Inc.

NAS: CNTX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 26, 2022, 6:38 p.m.

/zigman2/quotes/228313454/composite

$

2.09

Change

+0.01 +0.48%

Volume

Volume 3,529

Quotes are delayed by 20 min

/zigman2/quotes/228313454/composite

Previous close

$ 1.95

$ 2.08

Change

+0.13 +6.67%

Day low

Day high

$1.89

$2.15

Open

52 week low

52 week high

$1.27

$10.87

Open

Annual Financials for Context Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 201920202021 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense -----
Depreciation -----
Amortization of Intangibles -----
Gross Income -----
201920202021 5-year trend
SG&A Expense --5.38M2.57M7.44M
Research & Development --2.41M1.64M3.81M
Other SG&A --2.97M930,667-
Other Operating Expense -----
Unusual Expense --(93,365)(9.88M)2.95M
EBIT after Unusual Expense --(5.28M)7.31M(10.39M)
Non Operating Income/Expense -----
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense --1.1M661,22464,240
Gross Interest Expense --1.1M661,22464,240
Interest Capitalized -----
Pretax Income --(6.38M)6.64M(10.46M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income --(6.38M)6.64M(10.46M)
Minority Interest Expense -----
Net Income --(6.38M)6.64M(10.46M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries --(6.38M)6.64M(10.46M)
Preferred Dividends -----
Net Income Available to Common --(6.38M)6.64M(10.46M)
EPS (Basic) --(0.58)0.61(0.65)
Basic Shares Outstanding --10.96M10.96M15.97M
EPS (Diluted) --(0.58)0.61(0.65)
Diluted Shares Outstanding --10.96M10.96M15.97M
EBITDA --(5.38M)(2.57M)(7.44M)
Link to MarketWatch's Slice.